Deep Cell Technology Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $14.8M

  • Investors
  • 7

Deep Cell Technology General Information

Description

Provider of artificial intelligence-driven pharmaceutical development services intended for virtual cell innovation. The company offers interpretable virtual cell world models and a multi-scale unified learning framework, enabling molecular design and druggability optimization for pharmaceutical companies to improve drug development efficiency and reduce preclinical validation costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • KJ202-105, 2nd Floor, Building 6
  • Number 1 Courtyard, Zhongguancun East Road, Haidian District
  • Beijing, 100001
  • China
+86 136
Primary Industry
Discovery Tools (Healthcare)
Other Industries
IT Consulting and Outsourcing
Vertical(s)
Artificial Intelligence & Machine Learning
Corporate Office
  • KJ202-105, 2nd Floor, Building 6
  • Number 1 Courtyard, Zhongguancun East Road, Haidian District
  • Beijing, 100001
  • China
+86 136

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deep Cell Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 10-Aug-2026 $14.8M Completed Generating Revenue
To view Deep Cell Technology’s complete valuation and funding history, request access »

Deep Cell Technology Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Shunxi Private Equity Fund Management Growth/Expansion Minority
CAS Star Venture Capital Minority
Cenova Capital Venture Capital Minority
Prime Mont Capital Venture Capital Minority
Topview Innovation Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Deep Cell Technology FAQs

  • When was Deep Cell Technology founded?

    Deep Cell Technology was founded in 2025.

  • Where is Deep Cell Technology headquartered?

    Deep Cell Technology is headquartered in Beijing, China.

  • What industry is Deep Cell Technology in?

    Deep Cell Technology’s primary industry is Discovery Tools (Healthcare).

  • Is Deep Cell Technology a private or public company?

    Deep Cell Technology is a Private company.

  • What is Deep Cell Technology’s current revenue?

    The current revenue for Deep Cell Technology is .

  • How much funding has Deep Cell Technology raised over time?

    Deep Cell Technology has raised $14.8M.

  • Who are Deep Cell Technology’s investors?

    Beijing Shunxi Private Equity Fund Management, CAS Star, Cenova Capital, Prime Mont Capital, and Topview Innovation are 5 of 7 investors who have invested in Deep Cell Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process